Your search for bevacizumab returned 6 results

Leiter’s Compounding Pharmacy announced a voluntary recall of three lots of sterile products due to concerns with sterility assurance with its independent testing laboratory.

Avella Specialty Pharmacy announced a voluntary recall of Bevacizumab 1.25mg/0.05mL PF and Vancomycin PF (BSS) 1% due to lack of sterility assurance.

Due to lack of sterility assurance, Clinical Specialties is voluntarily recalling all lots of sterile products that were repackaged and distributed by the pharmacy. This recall follows the company’s recall of Avastin unit dose syringes on March 18th.

After reports surfaced of five intraocular infections at a physician’s office, Clinical Specialties is undertaking a voluntary recall of Avastin unit dose syringes. The sterile syringes were being used solely for an off-label indication by an ophthalmologist for macular degeneration.

The FDA has confirmed that a counterfeit version of Roche’s Altuzan 400mg/16mL (bevacizumab), an injectable cancer medication, found in the US contains no active ingredient.

The FDA is warning healthcare professional about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the U.S.